Clinton Scott Shultz
2Patents
0h-index
23Co-inventors
38Inventor score
Filing activity: Aug 16, 2012 → May 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11827614B2 | Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates | Chemistry; Metallurgy | 0 | Active |
| US9242917B2 | Crystal forms of a HCV protease inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.